HIV/AIDs in the U.S.

This is a curated page. Report corrections to Microbewiki.

An Introduction to HIV/AIDs

Mechanism of Infection of the Human Immunodeficiency Virus. [1].

By Jorge Sebastian Chavez Erazo

A Basic explanation of Antiretroviral Treatments

Include some current research, with at least one figure showing data.

Pre-/Post-Exposure Prophylaxis

In recent years, pre-exposure and post exposure prophylactic treatments for populations at high risk for Human Immunodeficiency Virus (HIV) infection have become increasingly studied and emphasized as vital to the decreased transmission of HIV resulting in decreased rates of Advanced Immunodeficiency Syndrome (AIDS) development in differing world populations.

Pre-Exposure Prophylaxis

PrEP has given a specific population the opportunity to have a 90% reduction in the chance of contracting HIV with the use of the daily pill, Truvada (oral emtricitabine (FTC)/ tenofovir disoproxil fumarate (TDF)). The product is said to be available to any person regardless of their sexual and gender identity but in there lies the problem with PrEP, many people who are at high risk of contracting HIV are not receiving it. .

Post-Exposure Prophylaxis

Include some current research, with at least one figure showing data.

Challenges to HIV/AIDs Prevention and Treatment

The product [PrEP] is said to be available to any person regardless of their sexual and gender identity but in there lies the problem with PrEP, many people who are at high risk of contracting HIV are not receiving it.

Conclusion

References

[1] aids.gov. "HIV AIDS 101".

[2] Blashill AJ, Ehlinger PP, Mayer KH, and Safren SA. "Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral Approach. 2015. Clinical Infectious Diseases 60(S3):S187-90.

Authored for BIOL 291.00 Health Service and Biomedical Analysis, taught by Joan Slonczewski, 2016, Kenyon College.